Bevacizumab and temozolomide in secondary gliomatosis from gemistocytic astrocytoma: a case report

@inproceedings{Trevisan2012BevacizumabAT,
  title={Bevacizumab and temozolomide in secondary gliomatosis from gemistocytic astrocytoma: a case report},
  author={Elisa Trevisan and Michela Magistrello and Roberta Rud{\`a} and Riccardo Soffietti},
  year={2012}
}
Gliomatosis cerebri is a rare diffuse glioma with a growth pattern consisting of exceptionally extensive infiltration of the CNS with involvement of at least three lobes. It may appear de novo (primary gliomatosis) or result from the spreading of a focal glioma (secondary gliomatosis). Bevacizumab is a monoclonal antibody anti-VEGF active against recurrent high grade gliomas after standard therapy. We report the case of a 41-year-old man with a secondary gliomatosis treated with bevacizumab and… CONTINUE READING